Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1091-1100 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|February 16, 2021
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapyColin D Godwin, George S Laszlo, Salvatore Fiorenza, et al.
Leukemia|February 18, 2021
Selective elimination of immunosuppressive T cells in patients with multiple myelomaMohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns, et al.
Leukemia|February 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemiaDamian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr, et al.
Leukemia|February 24, 2021
Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cellsArjun Thapa, Mateusz Adamiak, Kamila Bujko, et al.
Leukemia|April 1, 1988
Partial purification and biochemical characterization of human plasma thrombopoietinA M Vannucchi, A Grossi, D Rafanelli, et al.
Leukemia|September 1, 2019
An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLLSigrid S Skånland, Andrea Cremaschi, Henrik Bendiksen, et al.
Leukemia|October 26, 2018
Targeted killing of TNFR2-expressing tumor cells and T<sub>regs</sub> by TNFR2 antagonistic antibodies in advanced Sézary syndromeH Torrey, M Khodadoust, L Tran, et al.
Leukemia|December 1, 1987
Childhood leukemia: cerebrospinal fluid enolase isoenzymes in central nervous system infiltrationJ A Royds, R C Collin, W R Timperley, et al.
Leukemia|March 16, 2019
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBinu K Sasi, Claudio Martines, Elena Xerxa, et al.
Leukemia|November 1, 1988
Early effects of G- and GM-CSF upon HL-60 proliferation and differentiationL Elias, D E Van Epps
Pageof 963

Showing results (1091-1100 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|February 16, 2021
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapyColin D Godwin, George S Laszlo, Salvatore Fiorenza, et al.
Leukemia|February 18, 2021
Selective elimination of immunosuppressive T cells in patients with multiple myelomaMohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns, et al.
Leukemia|February 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemiaDamian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr, et al.
Leukemia|February 24, 2021
Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cellsArjun Thapa, Mateusz Adamiak, Kamila Bujko, et al.
Leukemia|April 1, 1988
Partial purification and biochemical characterization of human plasma thrombopoietinA M Vannucchi, A Grossi, D Rafanelli, et al.
Leukemia|September 1, 2019
An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLLSigrid S Skånland, Andrea Cremaschi, Henrik Bendiksen, et al.
Leukemia|October 26, 2018
Targeted killing of TNFR2-expressing tumor cells and T<sub>regs</sub> by TNFR2 antagonistic antibodies in advanced Sézary syndromeH Torrey, M Khodadoust, L Tran, et al.
Leukemia|December 1, 1987
Childhood leukemia: cerebrospinal fluid enolase isoenzymes in central nervous system infiltrationJ A Royds, R C Collin, W R Timperley, et al.
Leukemia|March 16, 2019
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBinu K Sasi, Claudio Martines, Elena Xerxa, et al.
Leukemia|November 1, 1988
Early effects of G- and GM-CSF upon HL-60 proliferation and differentiationL Elias, D E Van Epps
Pageof 963